Ylikorkala O, Mäkilä U M, Viinikka L
Br J Obstet Gynaecol. 1983 Mar;90(3):251-4. doi: 10.1111/j.1471-0528.1983.tb08619.x.
Serial plasma samples collected before and after vacuum curettage followed by methylergometrine injection in 10 women were assayed for 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha). The mean 6-keto-PGF1 alpha concentration was 97.2 (SE 8.8) pg/ml before cervical dilatation. The concentration rose to 128.2 (SE 13.5) pg/ml (P less than 0.10) immediately and to 133.3 (SE 17.8) pg/ml (P less than 0.05) 1 h after curettage and returned to the initial value within 5 h. Neither methylergometrine nor anaesthesia, nor non-gynaecological surgery, caused changes in the level of plasma 6-keto-PGF1 alpha. The capacity of the platelets to produce thromboxane A2 during spontaneous clotting of blood did not change during vacuum curettage, anaesthesia and non-gynaecological surgery, nor after methylergometrine. The evidence suggests that the pregnant myometrium and/or intrauterine tissues capable of generating prostacyclin (PGI2) in vitro may release PGI2 also in vivo.
对10名妇女在真空刮宫并注射甲基麦角新碱前后采集的系列血浆样本进行了6-酮-前列腺素F1α(6-酮-PGF1α)检测。宫颈扩张前6-酮-PGF1α的平均浓度为97.2(标准误8.8)pg/ml。刮宫后立即升至128.2(标准误13.5)pg/ml(P<0.10),1小时后升至133.3(标准误17.8)pg/ml(P<0.05),并在5小时内恢复到初始值。甲基麦角新碱、麻醉以及非妇科手术均未引起血浆6-酮-PGF1α水平的变化。在真空刮宫、麻醉、非妇科手术期间以及注射甲基麦角新碱后,血液自然凝固过程中血小板产生血栓素A2 的能力均未改变。有证据表明,在体外能够产生前列环素(PGI2)的妊娠子宫肌层和/或子宫内组织在体内也可能释放PGI2。